News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
73,241 Results
Type
Article (1933)
Company Profile (2)
Press Release (71306)
Section
Business (21467)
Career Advice (9)
Deals (4553)
Drug Development (8166)
FDA (1806)
Job Trends (800)
News (37031)
Policy (3567)
Tag
2027 BioCapital Standard (1)
Academia (97)
Accelerated approval (5)
ADA (2)
Allergies (20)
Alliances (8168)
ALS (15)
Alzheimer's disease (176)
Antibody-drug conjugate (ADC) (108)
Approvals (1957)
Artificial intelligence (33)
ASCO (37)
Autoimmune disease (32)
Automation (2)
Bankruptcy (8)
Best Places to Work (585)
BIO (7)
Biosimilars (84)
Biotechnology (5)
Bladder cancer (30)
Brain cancer (7)
Breast cancer (62)
Cancer (630)
Cardiovascular disease (26)
Career advice (9)
CAR-T (14)
CDC (1)
Cell therapy (58)
Cervical cancer (5)
Clinical research (7666)
Collaboration (326)
Compensation (25)
Complete response letters (6)
COVID-19 (203)
CRISPR (1)
C-suite (91)
Cystic fibrosis (8)
Data (815)
Depression (15)
Dermatology (11)
Diabetes (40)
Diagnostics (643)
Digital health (7)
Drug discovery (41)
Drug pricing (1)
Duchenne muscular dystrophy (42)
Earnings (8156)
Events (7579)
Executive appointments (70)
FDA (2290)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (149)
Gene editing (7)
Generative AI (1)
Gene therapy (39)
GLP-1 (81)
Government (242)
Grass and pollen (1)
Guidances (39)
Healthcare (1093)
Hematology (14)
HIV (6)
Huntington's disease (3)
IgA nephropathy (22)
Immunology and inflammation (7)
Immuno-oncology (11)
Indications (26)
Infectious disease (229)
Inflammatory bowel disease (25)
Inflation Reduction Act (1)
Influenza (14)
Intellectual property (38)
IPO (1641)
Job creations (241)
Job search strategy (9)
JPM (3)
Kidney cancer (1)
Layoffs (6)
Legal (955)
Liver cancer (19)
Longevity (3)
Lung cancer (113)
Lymphoma (51)
Machine learning (1)
Manufacturing (122)
MASH (19)
Medical device (1168)
Medtech (1184)
Mergers & acquisitions (3101)
Metabolic disorders (107)
mRNA (7)
Multiple sclerosis (23)
NASH (1)
Neurodegenerative disease (34)
Neuropsychiatric disorders (7)
Neuroscience (328)
NextGen: Class of 2026 (219)
Non-profit (64)
Obesity (36)
Opinion (1)
Ovarian cancer (35)
Pain (18)
Pancreatic cancer (28)
Parkinson's disease (49)
Partnered (3)
Patents (71)
Patient recruitment (71)
Peanut (1)
People (5175)
Pharmaceutical (2)
Pharmacy benefit managers (5)
Phase 1 (2074)
Phase 2 (3252)
Phase 3 (2891)
Pipeline (1135)
Policy (1)
Postmarket research (242)
Preclinical (712)
Press Release (2)
Prostate cancer (26)
Radiopharmaceuticals (25)
Rare diseases (84)
Real estate (606)
Regulatory (3020)
Reports (6)
Research institute (97)
Rett syndrome (1)
RNA editing (3)
RSV (3)
Schizophrenia (21)
Series A (31)
Series B (23)
Service/supplier (1)
Sickle cell disease (8)
Spinal muscular atrophy (5)
Sponsored (1)
Startups (423)
Stomach cancer (2)
Supply chain (12)
Vaccines (46)
Venture capital (7)
Weight loss (17)
Women's health (7)
Date
Today (9)
Last 7 days (47)
Last 30 days (244)
Last 365 days (2764)
2026 (1452)
2025 (2685)
2024 (3252)
2023 (3814)
2022 (7016)
2021 (6372)
2020 (5875)
2019 (3873)
2018 (3012)
2017 (3560)
2016 (3174)
2015 (4030)
2014 (3020)
2013 (2600)
2012 (2776)
2011 (2902)
2010 (2663)
Location
Africa (88)
Alabama (4)
Arizona (13)
Arkansas (1)
Asia (22233)
Australia (2482)
California (781)
Canada (456)
China (492)
Colorado (5)
Connecticut (23)
Delaware (6)
Europe (13407)
Florida (83)
Georgia (16)
Illinois (41)
India (50)
Indiana (25)
Japan (325)
Kansas (5)
Louisiana (2)
Maine (4)
Maryland (121)
Massachusetts (619)
Michigan (9)
Minnesota (37)
Missouri (3)
Nebraska (3)
Nevada (10)
New Hampshire (1)
New Jersey (470)
New York (278)
North Carolina (119)
Northern California (329)
Ohio (6)
Oregon (1)
Pennsylvania (147)
Puerto Rico (1)
Rhode Island (1)
South America (109)
South Carolina (1)
Southern California (384)
Tennessee (1)
Texas (59)
United States (2983)
Utah (29)
Vermont (1)
Virginia (58)
Washington D.C. (3)
Washington State (60)
Wisconsin (7)
73,241 Results for "kamada ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Kamada Announces FDA Approval of its New In-House Rabies Virus Neutralization Testing Laboratory
June 1, 2026
·
5 min read
Press Releases
Kamada to Announce First Quarter 2026 Financial Results on May 13, 2026
May 6, 2026
·
2 min read
Press Releases
Kamada Reports First Quarter 2026 Financial Results and Affirms 2026 Annual Guidance; Expecting Significantly Stronger Remainder of the Year
May 13, 2026
·
18 min read
Press Releases
Kamada Announces FDA Approval of its Plasma Collection Center in San Antonio, Texas
March 26, 2026
·
5 min read
Press Releases
Kamada to Announce Fiscal Year and Fourth Quarter 2025 Financial Results on March 11, 2026
March 4, 2026
·
2 min read
Press Releases
Kamada Declares Cash Dividend of $0.25 Per Share, to be Paid in Accordance with an Adopted Annual Cash Dividend Policy
March 11, 2026
·
5 min read
Press Releases
Kamada to Present at the Stifel 2025 Healthcare Conference
October 29, 2025
·
2 min read
Kamada to Participate in Upcoming September 2025 Investor Conferences
September 3, 2025
·
3 min read
Press Releases
Faron Pharmaceuticals Ltd: Registration of Treasury Shares
June 11, 2026
·
2 min read
Press Releases
Kamada Provides 2026 Annual Guidance of $200 - $205 Million in Revenues and $50 - $53 Million of Adjusted EBITDA, Representing Double-Digit Growth and Affirms 2025 Financial Guidance
January 7, 2026
·
10 min read
1 of 7,325
Next
